Shukra [SHUKRAPHAR] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Shukra Pharmaceuticals Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shukra Pharmaceuticals Ltd. wins in 10 metrics, Innova Captab Ltd. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Shukra Pharmaceuticals Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 770.20 31.20 Innova Captab Ltd.
Price-to-Book Ratio 22.86 4.05 Innova Captab Ltd.
Debt-to-Equity Ratio 5.71 32.95 Shukra Pharmaceuticals Ltd.
PEG Ratio 1.39 1.33 Innova Captab Ltd.
EV/EBITDA 34.62 20.49 Innova Captab Ltd.
Profit Margin (TTM) 45.16% 8.85% Shukra Pharmaceuticals Ltd.
Operating Margin (TTM) 67.87% 12.88% Shukra Pharmaceuticals Ltd.
EBITDA Margin (TTM) 67.87% 12.88% Shukra Pharmaceuticals Ltd.
Return on Equity 15.24% 13.37% Shukra Pharmaceuticals Ltd.
Return on Assets (TTM) 11.04% 8.12% Shukra Pharmaceuticals Ltd.
Free Cash Flow (TTM) $51.75M $-1.09B Shukra Pharmaceuticals Ltd.
Dividend Yield 3.20% 0.30% Shukra Pharmaceuticals Ltd.
1-Year Return 104.99% 3.87% Shukra Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 21.46 2.76 Innova Captab Ltd.
Enterprise Value $13.61B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 21.08 2.90 Innova Captab Ltd.
Gross Profit Margin (TTM) 81.77% 35.19% Shukra Pharmaceuticals Ltd.
Revenue per Share (TTM) $1 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $-0.20 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.94 -0.33 Innova Captab Ltd.

Shukra Pharmaceuticals Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

SHUKRAPHAR
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shukra Pharmaceuticals Ltd.3.57%-2.60%-1.15%-23.64%-42.21%-44.86%
Innova Captab Ltd.0.58%8.95%10.45%34.08%34.58%28.37%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shukra Pharmaceuticals Ltd.104.99%517.94%1,925.00%2,071.74%707.82%707.82%
Innova Captab Ltd.3.87%74.08%74.08%74.08%74.08%74.08%

Performance & Financial Health Analysis: Shukra Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricSHUKRAPHARINNOVACAP
Market Information
Market Cap i₹13.91B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i458,425578,151
90 Day Avg. Volume i341,812217,693
Last Close₹31.04₹947.95
52 Week Range₹12.97 - ₹65.26₹622.00 - ₹978.00
% from 52W High-52.44%-3.07%
All-Time High₹65.26 (Dec 19, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-52.44%-24.77%
Growth Metrics
Quarterly Revenue Growth2.45%0.42%
Quarterly Earnings Growth5.44%0.23%
Financial Health
Profit Margin (TTM) i0.45%0.09%
Operating Margin (TTM) i0.68%0.13%
Return on Equity (TTM) i0.15%0.13%
Debt to Equity (MRQ) i5.7132.95
Cash & Liquidity
Book Value per Share (MRQ)₹1.38₹178.28
Cash per Share (MRQ)₹0.31₹10.22
Operating Cash Flow (TTM) i₹66.80M₹282.88M
Levered Free Cash Flow (TTM) i₹95.75M₹1.28B
Dividends
Last 12-Month Dividend Yield i3.20%0.30%
Last 12-Month Dividend i₹1.02₹2.00

Valuation & Enterprise Metrics Analysis: Shukra Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricSHUKRAPHAR (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i770.2031.20
Forward P/E iN/A21.90
PEG Ratio i1.391.33
Price to Sales (TTM) i21.462.76
Price to Book (MRQ) i22.864.05
Market Capitalization
Market Capitalization i₹13.91B₹41.43B
Enterprise Value i₹13.61B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i21.082.90
Enterprise to EBITDA i34.6220.49
Risk & Other Metrics
Beta i0.94-0.33
Book Value per Share (MRQ) i₹1.38₹178.28

Financial Statements Comparison: Shukra Pharmaceuticals Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSHUKRAPHAR (2025)INNOVACAP (2025)
Revenue/Sales i325.87M12.34B
Cost of Goods Sold i81.12M8.38B
COGS % of Revenue i24.9%67.9%
Gross Profit i244.76M3.96B
Gross Margin i75.1%32.1%
Research & Development i1.66MN/A
Operating Income (EBIT) i97.25M1.65B
Operating Margin i29.8%13.4%
EBITDA i168.63M2.00B
EBITDA Margin i51.7%16.2%
Pre-Tax Income i133.37M1.71B
Pre-Tax Income % of Revenue i40.9%13.9%
Income Tax i37.61M427.58M
Income Tax % of Revenue i11.5%3.5%
Net Income (Profit) i95.75M1.28B
Profit Margin i29.4%10.4%

Balance Sheet & Liquidity Metrics

MetricSHUKRAPHAR (2025)INNOVACAP (2025)
Cash & Equivalents i121.18M155.19M
Total Current Assets i654.27M7.03B
Total Current Assets % of Revenue i200.8%57.0%
Total Current Liabilities i172.84M3.53B
Total Current Liabilities % of Revenue i53.0%28.6%
Long-Term Debt i31.13M2.45B
Long-Term Debt % of Revenue i9.6%19.8%
Total Shareholders Equity i628.36M9.59B
Retained Earnings i143.00M4.53B
Retained Earnings % of Revenue i43.9%36.7%
Property, Plant & Equipment i193.97M442.93M

Cash Flow Statement Comparison

MetricSHUKRAPHAR (2025)INNOVACAP (2025)
Operating Cash Flow i66.80M282.88M
Operating Cash Flow % of Revenue i20.5%2.3%
Capital Expenditures i-27.43M-1.72B
Free Cash Flow i51.75M-1.09B
FCF Margin i15.9%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSHUKRAPHARINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i437.88M57.22M
Float Shares i46.25M15.91M
% Held by Insiders i89.33%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i10.67%8.59%

Dividend Analysis & Yield Comparison: Shukra Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricSHUKRAPHARINNOVACAP
Last 12-Month Dividend i₹1.02₹2.00
Last 12-Month Dividend Yield i3.20%0.30%
3-Year Avg Annual Dividend i₹0.35₹0.67
3-Year Avg Dividend Yield i3.91%0.30%
3-Year Total Dividends i₹1.05₹2.00
Ex-Dividend DateSep 23, 2025Jan 30, 2026